{
  "report_rows": [
    {
      "kpi": "Q2 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$10.95 vs. cons $10.80",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.045B vs. cons $1.030B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 local-currency sales growth",
      "prediction": "BEAT",
      "answer": "pred ~3.5% vs. cons 3.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$46.65 vs. cons $46.70 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 local-currency sales-growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~4.0% vs. cons 4.0% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 adjusted EPS guidance",
      "prediction": "LOWER",
      "answer": "guide ~$12.15 vs. cons $12.30 (Q3 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.0,
  "day5_path": "FADE",
  "day5_rationale": "A Q2 beat on pricing, China and productivity should drive an initial positive reaction, but an effectively unchanged FY2026 EPS framework (~$46.65 vs. ~$46.70 consensus) and softer implied Q3 EPS (~$12.15 vs. ~$12.30 consensus) leave out-period estimates vulnerable to modest cuts.",
  "day5_confidence": "MEDIUM"
}